Mary J. Ortner

Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner.